These results, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 guidance the principle of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders. A brand new review reveals that https://brucet959xdp3.answerblogs.com/profile